On November 10, 2023, Gan & Lee Pharmaceuticals. closed the transaction. The company issued 28,508,550 A shares at an issue price of CNY 27.12 per share for the gross proceeds of CNY 773,151,876.

After deducting the payment of underwriting and sponsor fees, legal fees and other issuance expenses totaling CNY 13,423,907.93, the net raised funds were CNY 759,727,968.07, of which CNY 28,508,550.00 were included in the share capital. CNY 731,219,418.07 were included in the capital reserve. All shares were subscribed by individual investor Gan Zhongru.